Hepatitis-associated aplastic anemia

New England Journal of Medicine

Volumn 336, Issue 15, 1997, Pages 1059-1064

  Brown, Kevin E ^a,b   Tisdale, John ^a   Barrett, A John ^a   Dunbar, Cynthia E ^a   Young, Neal S ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; THYMOCYTE ANTIBODY; VIRUS RNA;

ACUTE HEPATITIS; ADOLESCENT; ADULT; APLASTIC ANEMIA; ARTICLE; BONE MARROW TRANSPLANTATION; CLINICAL ARTICLE; DIAGNOSTIC APPROACH ROUTE; DISEASE ASSOCIATION; FEMALE; HEPATITIS VIRUS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; PRIORITY JOURNAL; SCHOOL CHILD; SEROLOGY; TREATMENT PLANNING; VIRUS DETECTION;

ADOLESCENT; ADULT; ANEMIA, APLASTIC; ANTILYMPHOCYTE SERUM; CHILD; CYCLOSPORINE; FEMALE; HEPATITIS; HEPATITIS B; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LEUKOCYTE COUNT; MALE; RECURRENCE; RETROSPECTIVE STUDIES; TRANSAMINASES; TREATMENT OUTCOME;

EID: 0030892008     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199704103361504     Document Type: Article

References (37)

1. Lorenz E, Quaiser K. Panmyelopathie nach Hepatitis epidemica. Wien Med Wochenschr 1955;105:19-22.
2. Fomina LG. K voprosu obizmenenii krovetvoreniia pri zabolevaniiakh pecheni. Sov Med 1955;19(6):28-31.
3. Hagler L, Pastore RA, Bergin JJ, Wrensch MR. Aplastic anemia following viral hepatitis: report of two fatal cases and literature review. Medicine (Baltimore) 1975;54:139-64.
4. Böttiger LE, Westerholm B. Aplastic anaemia. III. Aplastic anaemia and infectious hepatitis. Acta Med Scand 1972;192:323-6.
5. Mary JY, Baumelou E, Guiguet M. Epidemiology of aplastic anemia in France: a prospective multicentric study. Blood 1990;75:1646-53.
6. Young NS, Issaragrisil S, Chieh CW, Takaku F. Aplastic anaemia in the Orient. Br J Haematol 1986;62:1-6.
7. Liang DC, Lin KH, Lin DT, Yang CP, Hung KL, Lin KS. Post-hepatitis aplastic anaemia in children in Taiwan, a hepatitis prevalent area. Br J Haematol 1990;74:487-91.
8. Hibbs JR, Frickhofen N, Rosenfeld SJ, et al. Aplastic anemia and viral hepatitis: non-A, non-B, non-C? JAMA 1992;267:2051-4.
9. Pol S, Driss F, Devergie A, Brechot C, Berthelot P, Gluckman E. Is hepatitis C virus involved in hepatitis-associated aplastic anemia? Ann Intern Med 1990;113:435-7.
10. Tzakis AG, Arditi M, Whitington PF, et al. Aplastic anemia complicating orthotopic liver transplantation for non-A, non-B hepatitis. N Engl J Med 1988;319:393-6.
11. Cattral MS, Langnas AN, Markin RS, et al. Aplastic anemia after liver transplantation for fulminant liver failure. Hepatology 1994;20:813-8.
12. Sallie R, Silva AE, Purdy M, et al. Hepatitis C and E in non-A non-B fulminant hepatic failure: a polymerase chain reaction and serological study. J Hepatol 1994;20:580-8.
13. Rosenfeld SJ, Kimball J, Vining D, Young NS. Intensive immunosuppression with antithymocyte globulin and cyclosporine as treatment for severe acquired aplastic anemia. Blood 1995;85:3058-65.
14. Simons JN, Leary TP, Dawson GJ, et al. Isolation of novel virus-like sequences associated with human hepatitis. Nat Med 1995;1: 564-9.
15. Linnen J, Wages J Jr, Zhang-Keck ZY, et al. Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science 1996;271:505-8.
16. Hibbs JR, Issaragrisil S, Young NS. High prevalence of hepatitis C viremia among aplastic anemia patients and controls from Thailand. Am J Trop Med Hyg 1992;46:564-70.
17. Leary TP, Muerhoff AS, Simons JN, et al. Consensus oligonucleotide primers for the detection of GB virus C in human cryptogenic hepatitis. J Virol Methods 1996;56:119-21.
18. Kagan WA, Ascensao JA, Pahwa RN, et al. Aplastic anemia: presence in human bone marrow of cells that suppress myelopoiesis. Proc Natl Acad Sci U S A 1976;73:2890-4.
19. Zoumbos NC, Gascón P, Djeu JY, Trost SR, Young NS. Circulating activated suppressor T lymphocytes in aplastic anemia. N Engl J Med 1985;312:257-65.
20. Maciejewski JP, Hibbs JR, Anderson S, Katevas P, Young NS. Bone marrow and peripheral blood lymphocyte phenotype in patients with bone marrow failure. Exp Hematol 1994;22:1102-10.
21. Nakao S, Yamaguchi M, Shiobara S, et al. Interferon-gamma gene expression in unstimulated bone marrow mononuclear cells predicts a good response to cyclosporine therapy in aplastic anemia. Blood 1992;79:2532-5.
22. Nisticó A, Young NS. Gamma-interferon gene expression in the bone marrow of patients with aplastic anemia. Ann Intern Med 1994;120:463-9.
23. Chisari FV, Ferrari C. Hepatitis B virus immunopathogenesis. Annu Rev Immunol 1995;13:29-60.
24. Liaw YF, Lee CS, Tsai SL, et al. T-cell-mediated autologous hepatocytotoxicity in patients with chronic hepatitis C virus infection. Hepatology 1995;22:1368-73.
25. Kojima S, Matsuyama K, Kodera Y, Okada J. Circulating activated suppressor T lymphocytes in hepatitis-associated aplastic anaemia. Br J Haematol 1989;71:147-51.
26. Camitta BM, Nathan DG, Forman EN, Parkman R, Rappeport JM, Orellana TD. Posthepatic severe aplastic anemia - an indication for early bone marrow transplantation. Blood 1974;43:473-83.
27. Gluckman E, Devergie A, Faille A, Bussel A, Benbunan M, Bernard J. Antilymphocyte globulin treatment in severe aplastic anemia - comparison with bone marrow transplantation: report of 60 cases. Haematol Bluttransfus 1979;24:171-9.
28. May WS, Sensenbrenner LL, Burns WH, et al. BMT for severe aplastic anemia using cyclosporine. Bone Marrow Transplant 1993;11:459-64.
29. Storb R, Etzioni R, Anasetti C, et al. Cyclophosphamide combined with antithymocyte globulin in preparation for allogeneic marrow transplants in patients with aplastic anemia. Blood 1994;84:941-9.
30. Champlin RE, Horowitz MM, van Bekkum DW, et al. Graft failure following bone marrow transplantation for severe aplastic anemia: risk factors and treatment results. Blood 1989;73:606-13.
31. Bradley BA, Hows JM, Gore SM, et al. Current status of unrelated-donor bone marrow transplantation: the International Marrow Unrelaed Search and Transplant (IMUST) Study. Clin Transpl 1992:91-107.
32. Passweg JR, Socié G, Hinterberger W, et al. Bone marrow transplantation for severe aplastic anemia: has outcome improved? Blood (in press).
33. Gluckman E, Horowitz MM, Champlin RE, et al. Bone marrow transplantation for severe aplastic anemia: influence of conditioning and graft-versus-host disease prophylaxis regimens on outcome. Blood 1992;79: 269-75.
34. Kernan NA, Bartsch G, Ash RC, et al. Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. N Engl J Med 1993;328:593-602.
35. Margolis D, Camitta B, Pietryga D, et al. Unrelated donor bone marrow transplantation to treat severe aplastic anaemia in children and young adults Br J Haematol 1996;94:65-72.
36. Shannon K, Koehne W, Heyman MB, Koerper MA. Relapsing post-hepatitis aplastic anemia: immunosuppressive therapy. Clin Pediatr (Phila) 1990;29:25-9.
37. Shimokawa T, Suzue T. Successful treatment of a case of hepatitis-associated severe aplastic anemia by anti-lymphocyte globulin (ALG). Rinsho Ketsueki 1990;31:1836-9. (In Japanese.)